News and Announcements
YPB Announces Operation Leadership Change
- Published July 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Brand Protection and Customer Connection solutions company YPB Group Ltd (ASX: YPB) announced the resignation of CEO Jens Michel effective immediately, with founder and major shareholder John Houston to resume operational leadership.
KEY TAKEAWAYS:
- YPB’s CEO Jens Michel resigns effective immediately
- Founder and major shareholder John Houston to resumeoperationalleadership
Founder and major shareholder John Houston will resumeoperational leadership. All attention and effort will be funnelled into converting the A$122m new business pipeline to revenue and completion of the 40% overhead reduction plan in order to drive the company into profitability as quickly as possible.
YPB Executive Chairman John Houston said: “I would like to personally thank Jens for his service over the past 21 months and wish him the very best in his future career. For the remainder of 2017, I am determined to focus the Company and all its resources on closing revenue opportunities in our well-developed pipeline and delivering the Company into profitability.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
